TSX:CURA

Curaleaf Holdings, Inc. · TSX · Healthcare · CAD · FY for 2025

Figures on this page computed 2026-11-08 12:41 UTC

Last close

n/aCAD

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CAD
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CAD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-18.5%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CAD
- Computed from the filing for 2025
- Computed from the filing for 2025
6.0%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CAD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CAD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
CAD
- computed

Safety is the furthest below its sector's middle: 0.24 against 0.53 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.70x

1.66x

-1.56x

1.98x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales1.70x
Its own average over 10 years, 745.1M.
Profit1.66x
Its own average over 10 years, -141.8M.
Free cash flow-1.56x
Its own average over 10 years, -48.4M.
Debt1.98x
Its own average over 10 years, 523.7M.
Pricen/a
Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at -1.56 times.

Sales is 1.70 times its own 10-year average; Profit is 1.66 times its own 10-year average; Free cash flow is -1.56 times its own 10-year average; Debt is 1.98 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales against its own 10-year average1.70
Source
computed
Statement
income
Fiscal year
2025
Reported in
USD
Profit against its own 10-year average1.66
Source
computed
Statement
income
Fiscal year
2025
Reported in
USD
Free cash flow against its own 10-year average-1.56
Source
computed
Statement
income
Fiscal year
2025
Reported in
USD
Debt against its own 10-year average1.98
Source
computed
Statement
income
Fiscal year
2025
Reported in
USD
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
CAD